See All Slides - tctmd.com

Slides

Presentation TCT 2014

Evolution of Echo Assessment: LAA/Mitral Intervention

Presenter: Rebecca T. Hahn

September 14, 2014

Presentation TCT 2014

Transapical TAVR Is a Worthy Alternative Recent Outcomes, Advantages, and Optimal Patient Profile!

Presenter: Thomas Walther

September 16, 2014

Presentation TCT 2014

China Provider Perspective

Presenter: Jack C. Lewin, Run-Lin Gao

September 13, 2014

Presentation TCT 2014

My Worst Radial Case Last Year and What I Learned

Presenter: Olivier F. Bertrand, Philippe Généreux, David E. Kandzari, Yves R. Louvard

September 16, 2014

Presentation TCT 2014

Left Main Restenosis: Frequency, Implications, and Management

Presenter: Davide Capodanno, Evald H. Christiansen, R. Stefan Kiesz, Adrian P. Banning

September 16, 2014

Presentation TCT 2014

Con: The Psychological Attraction Will Pass When the Data Emerges!

Presenter: Daniel I. Simon

September 16, 2014

Presentation TCT 2014

LAA Occlusion Devices Stuck in the Mud Matching the Right Patients with the Best Trial Designs (and Endpoints)

Presenter: Matthew G. Hillebrenner, Gregg W. Stone, Matthew J. Price, Brian K. Whisenant

September 16, 2014

Presentation TCT 2014

Case Presentation

Presenter: Tamim Nazif

September 16, 2014

Presentation TCT 2014

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Presenter: Saibal Kar

September 16, 2014

Presentation TCT 2014

Advanced HT Failure Therapies in 2014: LVAD or Transplant?

Presenter: Daniel Burkhoff, Mark Goldberger, Finn Gustafsson

September 16, 2014

Advertisement

Slides

Evolution of Echo Assessment: LAA/Mitral Intervention

Transapical TAVR Is a Worthy Alternative Recent Outcomes, Advantages, and Optimal Patient Profile!

China Provider Perspective

My Worst Radial Case Last Year and What I Learned

Left Main Restenosis: Frequency, Implications, and Management

Con: The Psychological Attraction Will Pass When the Data Emerges!

LAA Occlusion Devices Stuck in the Mud Matching the Right Patients with the Best Trial Designs (and Endpoints)

Case Presentation

Outcomes Following Percutaneous Reduction of Significant Mitral Regurgitation in EVEREST II High Risk Patients Who Were Symptomatic Despite Cardiac Resynchronization Therapy

Advanced HT Failure Therapies in 2014: LVAD or Transplant?

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content